Abstract
Coronary artery disease (CAD) is regarded as the principal cause of cardiovascular diseases and one of the leading causes of mortality. In order to alleviate the risk of CAD, percutaneous coronary intervention (PCI) and stent implantation have recently been applied. In particular, Mg alloy (Mg-alloy) stents (MAS) have been used as clinical routine for the treatment of CAD. However, emerging evidence suggests that this treatment strategy is substantially associated with coronary in-stent restenosis (ISR), which remains the main cause of unintentional and repeat drug-eluting stent (DES) interventions in the United States. In this regard, understanding of MAS as friend or foe of ISR treatment is needed to establish the exact mechanism underlying this condition. This mini review therefore aimed to provide an integrated view on the existing findings of the relationship between MAS and ISR. The understanding of MAS as either a friend or foe is crucial for the management of ISR, which is reported to be very challenging amidst lack of effective therapeutic options.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
